NasdaqGM:CERSMedical Equipment
Cerus (CERS) Revenue Growth Outpaces Market And Reinforces Bullish Margin Recovery Narrative
Cerus (CERS) has just closed out FY 2025 with Q4 revenue of US$57.8 million and a basic EPS loss of US$0.01, while trailing 12 month figures sit at US$206.1 million in revenue and a basic EPS loss of US$0.08. Over recent quarters the company has seen revenue move from US$50.8 million in Q4 2024 to US$43.2 million in Q1 2025, then to US$52.4 million in Q2, US$52.7 million in Q3 and US$57.8 million in Q4, with basic EPS losses ranging between US$0.00 and US$0.04 per share across the same...